• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用决策算法优化急诊腹主动脉瘤腔内修复术中的股动脉入路

Optimizing Femoral Access in Emergency EVAR with a Decision-Making Algorithm.

作者信息

Mirabella Domenico, Bruno Salvatore, La Marca Manfredi Agostino, Dinoto Ettore, Rodriquenz Edoardo, Miccichè Andrea, Pecoraro Felice

机构信息

Vascular Surgery Unit, AOUP Policlinico "P. Giaccone", 90127 Palermo, Italy.

Department of Surgical, Oncological and Oral Sciences, University of Palermo, 90133 Palermo, Italy.

出版信息

Life (Basel). 2024 Sep 4;14(9):1113. doi: 10.3390/life14091113.

DOI:10.3390/life14091113
PMID:39337897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11433623/
Abstract

Endovascular aneurysm repair (EVAR) has become the preferred approach over open repair for abdominal aortic aneurysms (AAAs) due to its minimally invasive nature. The common femoral artery (CFA) is the main access vessel for EVAR, with both surgical exposure and percutaneous access being utilized. However, in emergent cases, percutaneous access can be challenging and may result in complications such as bleeding or dissection thrombosis, leading to the need for surgical conversion. This study aimed to share experiences in implementing a decision-making algorithm to reduce surgical conversions due to percutaneous access failures. A total of 74 aortic patients treated with EVAR in emergency settings were included in this retrospective study. This study focused on various outcomes such as perioperative mortality, morbidity, procedure time, surgical exposure time, and surgical conversion rate. After the implementation of the decision-making algorithm, decreases in surgical conversions and operating time were observed. Percutaneous access was found to be more challenging in cases with specific anatomical characteristics of the CFA, such as severe atherosclerosis or smaller vessel diameter. This study highlighted the importance of carefully assessing patient anatomical features and utilizing a decision-making algorithm to optimize outcomes in EVAR procedures. Further research is needed to continue improving practices for managing aortic aneurysms and reducing complications in femoral artery access approaches.

摘要

由于血管内动脉瘤修复术(EVAR)具有微创性,它已成为腹主动脉瘤(AAA)开放修复术的首选方法。股总动脉(CFA)是EVAR的主要入路血管,手术暴露和经皮穿刺入路均可采用。然而,在紧急情况下,经皮穿刺入路可能具有挑战性,可能导致出血或夹层血栓形成等并发症,从而需要转为手术治疗。本研究旨在分享实施决策算法以减少因经皮穿刺失败导致手术转为开放手术的经验。本回顾性研究纳入了74例在急诊情况下接受EVAR治疗的主动脉疾病患者。本研究关注围手术期死亡率、发病率、手术时间、手术暴露时间和手术转化率等各种结果。实施决策算法后,手术转化率和手术时间均有所下降。发现CFA具有特定解剖特征的病例,如严重动脉粥样硬化或血管直径较小,经皮穿刺入路更具挑战性。本研究强调了仔细评估患者解剖特征并利用决策算法优化EVAR手术结果的重要性。需要进一步研究以继续改进主动脉瘤管理实践并减少股动脉入路方法中的并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/db80fac785a7/life-14-01113-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/89c19496a6af/life-14-01113-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/da867e477638/life-14-01113-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/f2bbae4357c5/life-14-01113-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/d65d254f1c2a/life-14-01113-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/db80fac785a7/life-14-01113-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/89c19496a6af/life-14-01113-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/da867e477638/life-14-01113-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/f2bbae4357c5/life-14-01113-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/d65d254f1c2a/life-14-01113-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3efa/11433623/db80fac785a7/life-14-01113-g005.jpg

相似文献

1
Optimizing Femoral Access in Emergency EVAR with a Decision-Making Algorithm.使用决策算法优化急诊腹主动脉瘤腔内修复术中的股动脉入路
Life (Basel). 2024 Sep 4;14(9):1113. doi: 10.3390/life14091113.
2
Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis.腹主动脉瘤的血管内修复:一项基于证据的分析。
Ont Health Technol Assess Ser. 2002;2(1):1-46. Epub 2002 Mar 1.
3
Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.经皮与外科切开股动脉入路在择期分叉腹主动脉血管内修复术中的比较。
Cochrane Database Syst Rev. 2023 Jan 11;1(1):CD010185. doi: 10.1002/14651858.CD010185.pub4.
4
Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.经皮完全穿刺与手术切开股动脉入路用于择期分叉型腹主动脉瘤腔内修复术
Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD010185. doi: 10.1002/14651858.CD010185.pub3.
5
Totally percutaneous versus standard femoral artery access for elective bifurcated abdominal endovascular aneurysm repair.完全经皮入路与标准股动脉入路用于择期分叉腹主动脉瘤腔内修复术的比较。
Cochrane Database Syst Rev. 2014 Feb 27(2):CD010185. doi: 10.1002/14651858.CD010185.pub2.
6
Preoperative risk score for access site failure in ultrasound-guided percutaneous aortic procedures.超声引导经皮主动脉介入治疗中入路失败的术前风险评分。
J Vasc Surg. 2019 Oct;70(4):1254-1262.e1. doi: 10.1016/j.jvs.2018.12.025. Epub 2019 Mar 7.
7
Fenestrated endovascular grafts for the repair of juxtarenal aortic aneurysms: an evidence-based analysis.用于修复近肾主动脉瘤的开窗型血管内移植物:循证分析
Ont Health Technol Assess Ser. 2009;9(4):1-51. Epub 2009 Jul 1.
8
Safety of Percutaneous Femoral Access for Endovascular Aortic Aneurysm Repair Through Previously Surgically Exposed or Repaired Femoral Arteries.经手术暴露或修复的股动脉行经皮股动脉入路行血管内主动脉瘤修复的安全性。
J Endovasc Ther. 2023 Oct;30(5):730-738. doi: 10.1177/15266028221092980. Epub 2022 May 6.
9
Ultrasound-guided percutaneous endovascular aneurysm repair success is predicted by access vessel diameter.超声引导经皮血管内动脉瘤修复术的成功与入路血管直径相关。
J Vasc Surg. 2012 Jun;55(6):1554-61. doi: 10.1016/j.jvs.2011.12.042. Epub 2012 Feb 22.
10
Laparoscopic surgery for elective abdominal aortic aneurysm repair.择期腹主动脉瘤修复的腹腔镜手术
Cochrane Database Syst Rev. 2017 May 4;5(5):CD012302. doi: 10.1002/14651858.CD012302.pub2.

引用本文的文献

1
Minimally invasive management of chronic venous insufficiency: A case report on combined radiofrequency ablation and sclerotherapy in an obese patient.慢性静脉功能不全的微创治疗:肥胖患者联合射频消融与硬化疗法的病例报告
Int J Surg Case Rep. 2025 May;130:111290. doi: 10.1016/j.ijscr.2025.111290. Epub 2025 Apr 12.

本文引用的文献

1
Endurant Stent Graft for Treatment of Abdominal Aortic Aneurysm Inside and Outside of the Instructions for Use for the Proximal Neck: A 14-Year, Single-Center Experience.用于治疗腹主动脉瘤的Endurant覆膜支架移植物超出近端颈部使用说明范围:一项14年的单中心经验
J Clin Med. 2024 Apr 28;13(9):2589. doi: 10.3390/jcm13092589.
2
Insight from an Italian Delphi Consensus on EVAR feasibility outside the instruction for use: the SAFE EVAR Study.意大利关于在使用说明之外进行腔内修复术(EVAR)可行性的德尔菲共识见解:SAFE EVAR研究
J Cardiovasc Surg (Torino). 2024 Jun;65(3):273-279. doi: 10.23736/S0021-9509.23.12906-5. Epub 2024 Feb 6.
3
A Comparative Analysis of the Early and Late Complication Rates and the Effect of Calcification on the Efficacy of MANTA and ProGlide Vascular Closure Devices.
MANTA和ProGlide血管闭合装置早期和晚期并发症发生率的比较分析以及钙化对其疗效的影响
Cureus. 2023 Nov 1;15(11):e48092. doi: 10.7759/cureus.48092. eCollection 2023 Nov.
4
Outcome Analysis of Speed Gate Cannulation during Standard Infrarenal Endovascular Aneurysm Repair.标准肾下型血管腔内动脉瘤修复术中快速入路插管的结果分析
J Clin Med. 2023 Sep 28;12(19):6263. doi: 10.3390/jcm12196263.
5
A Multicenter Experience of Three Different "Iliac Branched" Stent Grafts for the Treatment of Aorto-Iliac And/Or Iliac Aneurysms.三种不同“髂支”支架移植物治疗主髂及/或髂动脉瘤的多中心经验。
Ann Vasc Surg. 2023 Aug;94:331-340. doi: 10.1016/j.avsg.2023.02.033. Epub 2023 Mar 13.
6
The effect of percutaneouS vs. cutdoWn accEss in patients after Endovascular aorTic repair (SWEET): Study protocol for a single-blind, single-center, randomized controlled trial.血管腔内主动脉修复术后经皮穿刺与切开入路的效果比较(SWEET):一项单盲、单中心随机对照试验的研究方案
Front Cardiovasc Med. 2022 Aug 19;9:966251. doi: 10.3389/fcvm.2022.966251. eCollection 2022.
7
Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial.经股动脉主动脉瓣置换术中纯封堵器与主缝合法血管闭合装置策略的比较:CHOICE-CLOSURE 随机临床试验。
Circulation. 2022 Jan 18;145(3):170-183. doi: 10.1161/CIRCULATIONAHA.121.057856. Epub 2021 Nov 5.
8
Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: Initial experience from a large European center.经导管主动脉瓣植入术后使用Manta与Perclose ProGlide血管闭合装置的比较:来自欧洲大型中心的初步经验。
Cardiovasc Revasc Med. 2022 Apr;37:34-40. doi: 10.1016/j.carrev.2021.06.134. Epub 2021 Jul 3.
9
Simultaneous Hybrid Treatment of Multilevel Peripheral Arterial Disease in Patients with Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血患者多节段外周动脉疾病的同步混合治疗
J Clin Med. 2021 Jun 28;10(13):2865. doi: 10.3390/jcm10132865.
10
Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI.评价 MANTA 血管闭合装置在经股动脉 TAVI 中的应用。
Thorac Cardiovasc Surg. 2023 Mar;71(2):84-93. doi: 10.1055/s-0041-1730972. Epub 2021 Jun 27.